News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
671,018 Results
Type
Article (55313)
Company Profile (418)
Press Release (615287)
Section
Business (183597)
Career Advice (3234)
Deals (32722)
Drug Delivery (111)
Drug Development (82375)
Employer Resources (178)
FDA (16109)
Job Trends (14467)
News (322397)
Policy (32075)
Tag
Academia (2907)
Alliances (46513)
Alzheimer's disease (1327)
Approvals (16017)
Artificial intelligence (144)
Bankruptcy (321)
Best Places to Work (11655)
Biotechnology (324)
Breast cancer (128)
Cancer (1160)
Cardiovascular disease (107)
Career advice (2723)
Cell therapy (268)
Clinical research (64953)
Collaboration (409)
Compensation (193)
COVID-19 (2741)
C-suite (104)
Data (1142)
Diabetes (166)
Diagnostics (6115)
Drug pricing (96)
Earnings (69779)
Employer resources (157)
Events (109758)
Executive appointments (315)
FDA (16661)
Funding (371)
Gene therapy (201)
GLP-1 (672)
Government (4861)
Healthcare (19637)
Infectious disease (2832)
Inflammatory bowel disease (120)
Interviews (627)
IPO (15498)
Job creations (3197)
Job search strategy (2245)
Layoffs (459)
Legal (7038)
Lung cancer (188)
Manufacturing (194)
Medical device (12949)
Medtech (12952)
Mergers & acquisitions (17322)
Metabolic disorders (462)
Neuroscience (1631)
NextGen Class of 2024 (6938)
Non-profit (4833)
Northern California (1471)
Obesity (266)
Opinion (239)
Patents (112)
People (53545)
Phase I (20220)
Phase II (28632)
Phase III (21483)
Pipeline (462)
Postmarket research (2569)
Preclinical (8771)
Radiopharmaceuticals (257)
Rare diseases (244)
Real estate (5512)
Regulatory (21576)
Research institute (2545)
Resumes & cover letters (517)
Southern California (1297)
Startups (3515)
United States (13621)
Vaccines (633)
Weight loss (213)
Date
Today (132)
Last 7 days (803)
Last 30 days (3854)
Last 365 days (36674)
2024 (33632)
2023 (40775)
2022 (51714)
2021 (56274)
2020 (54820)
2019 (48192)
2018 (36564)
2017 (33471)
2016 (32944)
2015 (38039)
2014 (29963)
2013 (24998)
2012 (26604)
2011 (27059)
2010 (24563)
Location
Africa (919)
Arizona (142)
Asia (39296)
Australia (6889)
California (3343)
Canada (1282)
China (257)
Colorado (145)
Connecticut (153)
Europe (90989)
Florida (458)
Georgia (120)
Illinois (368)
Indiana (186)
Kansas (98)
Maryland (599)
Massachusetts (2694)
Michigan (161)
Minnesota (266)
New Jersey (954)
New York (958)
North Carolina (762)
Northern California (1471)
Ohio (137)
Pennsylvania (825)
South America (1244)
Southern California (1297)
Texas (462)
Washington State (373)
671,018 Results for "the als association".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
ProJenX Announces Receipt of $1M Hoffman ALS Clinical Trial Award from the ALS Association
ProJenX, Inc. announced the receipt of a $1M Hoffman ALS Clinical Trials Award from the ALS Association.
June 20, 2024
·
4 min read
Press Releases
Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association
November 19, 2024
·
6 min read
BioCapital
The ALS Association Announces Inaugural ‘ALS Nexus’ Conference
The ALS Association, the leading national non-profit organization dedicated to fighting ALS on every front, is excited to announce its inaugural ALS Nexus Conference, taking place July 14-17, 2024 at The Gaylord Texan Resort & Conference Center in Grapevine, Texas.
March 22, 2024
·
3 min read
Coave Therapeutics Receives Grant from the ALS Association to Advance its CTx-TFEB Program as a Potential Treatment for All Forms of ALS
Coave Therapeutics is delighted to announce that it is one of six organisations sharing $2.9 million in grants from the ALS Association that support the advancement of novel therapies for the treatment of amyotrophic lateral sclerosis.
February 29, 2024
·
5 min read
Esri Technology Used By ALS Therapy Development Institute to Map Clinical Trials
The ALS Therapy Development Institute (ALS TDI), a nonprofit biotech dedicated to ending amyotrophic lateral sclerosis (ALS), has used mapping technology from Esri, the global leader in location intelligence, to develop the ALS Trial Navigator.
June 21, 2024
·
4 min read
BioCapital
Hugh Hoffman’s Historic Gift to ALS Association Will Elevate Fight Against ALS
The ALS Association proudly announces the largest single gift in its history from the estate of the late philanthropist Hugh Hoffman.
February 12, 2024
·
4 min read
Genetown
Myrobalan Therapeutics Receives a Grant from the ALS Association to Advance its CSF1R Inhibitor Program
Myrobalan Therapeutics is honored to announce a $400,000 grant from the ALS Association to support the advancement of its colony-stimulating factor-1 receptor (CSF1R) inhibitor for the treatment of amyotrophic lateral sclerosis (ALS).
February 7, 2024
·
4 min read
Press Releases
Aclipse Therapeutics Selected to Present M102 ALS Clinical Development Program at Prestigious ALS and Motor Neurone Disease Symposia
November 7, 2024
·
3 min read
Press Releases
Asha Therapeutics Awarded Barnett Drug Development Grant by the ALS Association to Advance Novel Intra-Molecular Glue Inhibitor of SARM1 to Clinic and Announces Appointment of Disarm Therapeutics’ Founders to Company’s Scientific Advisory Board
November 13, 2024
·
6 min read
Press Releases
NRG Therapeutics Awarded Grant Funding from Target ALS to Support the Development of mPTP Inhibitors as Novel Treatments for ALS/MND
September 5, 2024
·
4 min read
1 of 67,102
Next
